CD69 and SBK1 as potential predictors of responses to PD-1/PD-L1 blockade cancer immunotherapy in lung cancer and melanoma

BACKGROUND: PD-1/PD-L1 blockade is a promising immunotherapeutic strategy with the potential to improve the outcomes of various cancers. However, there is a critically unmet need for effective biomarkers of response to PD-1/PD-L1 blockade. MATERIALS AND METHODS: Potential biomarkers of response to P...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zhang-Wei, Sun, Wei, Wen, Yi-Hui, Ma, Ren-Qiang, Chen, Lin, Chen, Wen-Qing, Lei, Wen-Bin, Wen, Wei-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421049/
https://www.ncbi.nlm.nih.gov/pubmed/36045683
http://dx.doi.org/10.3389/fimmu.2022.952059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421049/
https://www.ncbi.nlm.nih.gov/pubmed/36045683
http://dx.doi.org/10.3389/fimmu.2022.952059

Ejemplares similares